2023/0491 - RUXOLITINIB [5 MG CÁP/ COMP]
TED · 447330-2026Award noticeawardedNo deadline given
Value
Estimated€154,288 · 154,288.05 EUR
Awarded—
WinnerNOVARTIS FARMA - PROD.FARM SA
Who already wins at this buyer
Firms with recorded awards from Unidade Local de Saúde Santa Maria, E.P.E. in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| ROCHE Farmacêutica Química, LDA | 25 | — | 2026-08-11 |
| GILEAD SCIENCES, LDA | 23 | — | 2026-08-11 |
| SANOFI-PRODUTOS FARMACÊUTICOS,LDA | 17 | €1,569,649 | 2026-08-11 |
| TAKEDA-Farmaceuticos Portugal, Lda | 11 | €554,760 | 2026-08-11 |
| NOVARTIS FARMA - PROD.FARM SA | 11 | — | 2026-08-11 |
Full buyer profile: what Unidade Local de Saúde Santa Maria, E.P.E. buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
RUXOLITINIB [5 MG CÁP/ COMP]
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-06-30 | 2023/0491 - RUXOLITINIB [5 MG CÁP/ COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 100% |
| 2026-06-30 | 2023/0491 - RIBOCICLIB [200 MG CÁP/ COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 97% |
| 2026-06-24 | 2023/0491 - IBRUTINIB [420 MG CÁP/COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 97% |
| 2026-07-21 | 2023/0491 - ABEMACICLIB [150 MG CÁP/ COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 96% |
| 2026-05-27 | 2023/0491 - OSIMERTINIB [80 MG COMP] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 96% |
| 2026-08-11 | 2023/0492 - DURVALUMAB [50 MG/ ML 10 ML FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 96% |